Turning Cold Tumors Hot: Dual-Target Therapy Offers New Hope for Platinum-Resistant Ovarian Cancer
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
Researchers at Sun Yat-Sen University have developed a three-gene signature based on platinum resistance biology that predicts overall survival and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine